🇺🇸 FDA
Patent

US 8202549

Mesocellular oxide foams as hemostatic compositions and methods of use

granted A61KA61K9/0014A61K9/122

Quick answer

US patent 8202549 (Mesocellular oxide foams as hemostatic compositions and methods of use) held by The Regents of the University of California expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K9/0014, A61K9/122, A61P, A61P7/04